A Multicentre, Randomised, Phase III Trial of Platinum-based Chemotherapy Versus Non-platinum Chemotherapy, After ERCC1 Stratification, in Patients With Advanced/Metastatic Non-small Cell Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms ET
- 10 Jun 2017 Biomarkers information updated
- 25 Jul 2013 Accrual to date is 50% according to United Kingdom Clinical Research Network record.
- 01 Jul 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.